EAAT2 Antibodies

Santa Cruz Biotechnology features a diverse variety of EAAT2 monoclonal antibodies for investigating the excitatory amino acid transporter 2 (EAAT2) in various biological processes. EAAT2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EAAT2 is crucial for the regulation of glutamate levels in the central nervous system, playing a significant role in neurotransmission and preventing excitotoxicity. Proper EAAT2 functioning is essential for maintaining neuronal health and has implications in various neurological disorders, including epilepsy, Alzheimer's disease, and multiple sclerosis. The study of EAAT2 is vital for understanding synaptic function and developing potential therapeutic strategies. Researchers can explore EAAT2's role in neurotransmitter regulation and its impact on neurological conditions. EAAT2 investigation continues to reveal new insights into brain function and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support cutting-edge neuroscience research, enabling scientists to advance our understanding of neurological health and disease.